Rare subtypes of triple-negative breast cancers (TNBC) are a heterogenous group of
tumors, comprising 5–10% of all TNBCs. Despite accounting for an absolute number of …

Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent invasive
carcinomas that display differentiation of the neoplastic epithelium towards squamous cells …

Introduction: There is evidence for an association between peripheral blood eosinophil
count (PBEC) and response to cancer immunotherapy; however, such data is limited in …

Metaplastic breast cancers (MBC) encompass a group of highly heterogeneous tumors
which share the ability to differentiate into squamous, mesenchymal or neuroectodermal …

Therapeutic anti-PD-L1 antibodies are safe as a monotherapy, albeit with minimal efficacy in
triple-negative breast cancer (TNBC). This trial aimed to test the safety and efficacy of …

Metaplastic breast cancer is a rare and often chemo-refractory subtype of breast cancer with
poor prognosis and limited treatment options. Recent studies have reported overexpression …

Abstract Purpose: Metaplastic breast cancer (MpBC) is a rare subtype of breast cancer that
is commonly triple-negative and poorly responsive to neoadjuvant therapy in retrospective …

Introduction Spindle cell carcinoma is a rare subtype of metaplastic breast cancer, with triple-
negative (TNBC: estrogen receptor-negative/progesterone receptor-negative/human …

Prostate cancer is among the most common malignancies for men, with limited therapy
options for last stages of the tumor. There are some different options for treatment and …

Metaplastic breast cancer (MpBC) is a rare and aggressive histologic subtype of breast
cancer (BC) characterized by the presence of at least two cellular types, commonly epithelial …